Opko Health Inc Press Releases

OPK 
$9.65
*  
0.02
0.21%
Get OPK Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading OPK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)
12/15/2014 8:00:00 AM - Business Wire


A. H. Belo Corporation Announces Sale of the Former South Plant and Updates on Pension and Cash Taxes
12/15/2014 8:00:00 AM - Business Wire


Tiger Media Announces Agreement to Acquire Interactive Data, LLC
12/15/2014 8:00:00 AM - Business Wire


OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference
12/3/2014 8:30:00 AM - Business Wire
▲15.43 % Price Change since this news event. The Volume Ratio is 0.94.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization
11/25/2014 9:52:00 AM - Market Wire


OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference
11/13/2014 9:21:00 AM - Business Wire
▲14.74 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States
11/10/2014 8:37:00 AM - Business Wire
▲16.55 % Price Change since this news event. The Volume Ratio is 2.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


OPKO To Hold Conference Call on November 10, 2014
11/7/2014 11:31:00 AM - Business Wire
▲15.99 % Price Change since this news event. The Volume Ratio is 2.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


OPKO Announces Third Quarter Operating and Financial Results
11/7/2014 8:28:00 AM - Business Wire
▲15.57 % Price Change since this news event. The Volume Ratio is 2.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cocrystal Pharma Develops Novel Ebola Screening Technology
10/23/2014 9:25:00 AM - Market Wire
▲17.25 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve
10/9/2014 11:15:00 AM - Business Wire
▲15.02 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


OPKO Health Supports National Prostate Cancer Council Legislation
9/29/2014 10:02:00 AM - Business Wire